Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

ZOSYN IN PLASTIC CONTAINER

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Standard Dose
EQ 40MG BASE/ML;EQ 5MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ZOSYN IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050750 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PIPERACILLIN SODIUM; TAZOBACTAM SODIUM Form and strength INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2024-12-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZOSYN IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050750 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PIPERACILLIN SODIUM; TAZOBACTAM SODIUM Form and strength INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2024-12-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.